Haisco Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 562.01 million compared to CNY 728.11 million a year ago. Revenue was CNY 562.01 million compared to CNY 728.11 million a year ago. Net income was CNY 26.2 million compared to CNY 287.26 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to CNY 0.27 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to CNY 0.27 a year ago.